18(2):185 Multifunctionality and possible medical application of the BPC 157 peptide: literature and patent review Bock-Marquette I, Maar K, Maar S, Lippai B, Faskerti G, Gallyas F Jr, Olson EN, Srivastava D., International Immunopharmacology , 2023
It is not intended for human or animal consumption, diagnostic purposes, or therapeutic application
Regulatory and Ethical Considerations Current Approval Status (2026) As of 2026, neither cagrilintide nor retatrutide has received FDA approval for obesity treatment or metabolic applications
PMID 16916826
In this case, a person may benefit from supplementing with the active form of folate
Without a caloric deficit to force the body to oxidize those fatty acids as fuel, they circulate briefly and are re-stored